A Real-life Study to Learn About the Use and Effects of the CDK4/6 Inhibitors in Canadian Patients With Breast Cancer.
NCT05770713
·
clinicaltrials.gov ↗
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Sponsor
Pfizer